Advances in assessment and cognitive neurorehabilitation of HIV-related neurocognitive impairment.

Neurocognitive impairment (NCI) is present in around 40% of people with HIV and substantially affects everyday life, adherence to combined antiretroviral therapy (cART) and overall life expectancy. Suboptimal therapy regimen, opportunistic infections, substance abuse and highly prevalent psychiatric co-morbidities contribute to NCI in people with HIV. In this review, we highlight the need for efficacious treatment of HIV-related NCI through pharmacological approaches and cognitive neurorehabilitation, discussing recent randomized controlled trials in this domain.

Sealing porous anodic layers on AA2024-T3 with a low viscosity benzoxazine resin for corrosion protection in aeronautical applications.

In this paper, a 4-ethylphenol--phenylenediamine (4EP-PDA) benzoxazine has been applied and cured on previously anodized AA2024-T3 substrates. The porous surface oxide layers obtained from sulfo-tartaric anodizing appeared to be highly impregnated by the benzoxazine resin, sealing the anodic films. Through rheological, morphological and chemical characterization, the curing process has been identified to be the key step for the impregnation to occur, related to the low viscosity of the 4EP-PDA benzoxazine attained during thermal curing.